Celularity, Inc. (GXGX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Research Solutions, Inc.

PaySign, Inc.

Where Food Comes From, Inc.

Bakkt Holdings, Inc.

Science 37 Holdings, Inc.

FONAR Corp.

Harte-Hanks, Inc.

Inotiv, Inc.

Celularity, Inc.

Network-1 Technologies, Inc

Benson Hill, Inc.

Why is Celularity, Inc. ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -185.03% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -42.14

Negative results in Sep 25

INTEREST(9M) At USD 5.86 MM has Grown at 31.56%
NET PROFIT(HY) At USD -39.54 MM has Grown at -33.9%
RAW MATERIAL COST(Y) Grown by 125.51% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -20.78%, its profits have fallen by -149.3%

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -7.29% over the previous quarter and collectively hold 10.35% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 14.90% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -20.78% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Celularity, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Celularity, Inc.

-20.78%

-0.58

106.92%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

57.33%

EBIT Growth (5y)

-185.03%

EBIT to Interest (avg)

-42.14

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

4.70

Sales to Capital Employed (avg)

0.46

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

10.35%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.78

EV to EBIT

-0.85

EV to EBITDA

-1.00

EV to Capital Employed

-2.85

EV to Sales

1.02

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -6.56 MM

NET PROFIT(HY)

Higher at USD -39.54 MM

ROCE(HY)

Highest at 0%

INVENTORY TURNOVER RATIO(HY)

Highest at 8.4 times

-20What is not working for the Company

INTEREST(9M)

At USD 5.86 MM has Grown at 31.56%

NET PROFIT(HY)

At USD -39.54 MM has Grown at -33.9%

RAW MATERIAL COST(Y)

Grown by 125.51% (YoY

NET SALES(Q)

Lowest at USD 5.28 MM

Here's what is working for Celularity, Inc.

Operating Cash Flow

Highest at USD -6.56 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -39.54 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Inventory Turnover Ratio

Highest at 8.4 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Celularity, Inc.

Net Sales

At USD 5.28 MM has Fallen at -52.6%

over average net sales of the previous four periods of USD 11.15 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Net Profit

At USD -39.54 MM has Grown at -33.9%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Interest

At USD 5.86 MM has Grown at 31.56%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Net Sales

Lowest at USD 5.28 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Raw Material Cost

Grown by 125.51% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales